Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunosurveillance of cancer and the heat shock protein-CD91 pathway.

Literature DB >> 29784128

Immunosurveillance of cancer and the heat shock protein-CD91 pathway.

Abstract

The intracellular functions of heat shock proteins (HSPs) as chaperones of macromolecules are well known. Current observations point to a role of these chaperones in initiating and modulating immune responses to tumors via receptor(s) on dendritic cells. In this article we provide an insight into, and a basis for, the importance of these HSP-mediated immune responses in rejecting nascent and emerging tumors.

Entities: Chemical Disease Gene Species

Keywords: Chaperone; Dendritic cell; T regs; Tumor immunity

Mesh：

Substances：

Year: 2018 PMID： 29784128 PMCID： PMC6239979 DOI： 10.1016/j.cellimm.2018.05.007

Source DB: PubMed Journal: Cell Immunol ISSN： 0008-8749 Impact factor: 4.868

93 in total

1. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin.

Authors: S Basu; R J Binder; T Ramalingam; P K Srivastava
Journal: Immunity Date: 2001-03 Impact factor: 31.745

2. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway.

Authors: S Basu; R J Binder; R Suto; K M Anderson; P K Srivastava
Journal: Int Immunol Date: 2000-11 Impact factor: 4.823

3. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.

Authors: V Shankaran; H Ikeda; A T Bruce; J M White; P E Swanson; L J Old; R D Schreiber
Journal: Nature Date: 2001-04-26 Impact factor: 49.962

4. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.

Authors: J Wolfers; A Lozier; G Raposo; A Regnault; C Théry; C Masurier; C Flament; S Pouzieux; F Faure; T Tursz; E Angevin; S Amigorena; L Zitvogel
Journal: Nat Med Date: 2001-03 Impact factor: 53.440

5. CD91: a receptor for heat shock protein gp96.

Authors: R J Binder; D K Han; P K Srivastava
Journal: Nat Immunol Date: 2000-08 Impact factor: 25.606

6. Heat shock protein-peptide complexes elicit cytotoxic T-lymphocyte and antibody responses specific for bovine herpesvirus 1.

Authors: M Navaratnam; M S Deshpande; M J Hariharan; D S Zatechka; S Srikumaran
Journal: Vaccine Date: 2001-01-08 Impact factor: 3.641

7. HBV-specific peptide associated with heat-shock protein gp96.

Authors: S D Meng; T Gao; G F Gao; P Tien
Journal: Lancet Date: 2001-02-17 Impact factor: 79.321

8. Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity.

Authors: X Y Wang; L Kazim; E A Repasky; J R Subjeck
Journal: J Immunol Date: 2001-01-01 Impact factor: 5.422

9. The dual nature of specific immunological activity of tumor-derived gp96 preparations.

Authors: R Y Chandawarkar; M S Wagh; P K Srivastava
Journal: J Exp Med Date: 1999-05-03 Impact factor: 14.307

10. Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity.

Authors: S Basu; P K Srivastava
Journal: J Exp Med Date: 1999-03-01 Impact factor: 14.307

3 in total

Review 1. Agents of cancer immunosurveillance: HSPs and dsDNA.

Authors: Devanshi A Nayak; Robert J Binder
Journal: Trends Immunol Date: 2022-04-02 Impact factor: 16.687

2. Resection of Noncontrast-Enhancing Regions Deteriorated the Immunotherapeutic Efficacy of HSPPC-96 Vaccination in Treating Glioblastoma.

Authors: Xiaohan Chi; Yi Wang; Chunzhao Li; Xijian Huang; Hua Gao; Yang Zhang; Nan Ji
Journal: Front Oncol Date: 2022-05-18 Impact factor: 5.738

Review 3. Heat Shock Proteins in Cancer Immunotherapy.

Authors: Jugal Kishore Das; Xiaofang Xiong; Xingcong Ren; Jin-Ming Yang; Jianxun Song
Journal: J Oncol Date: 2019-12-11 Impact factor: 4.375

3 in total